Adverse Incidents Sample Clauses
The Adverse Incidents clause defines the obligations and procedures for reporting and managing unexpected negative events or accidents that occur during the course of an agreement or project. Typically, this clause requires parties to promptly notify each other of any incidents that could cause harm, loss, or liability, and may outline steps for investigation, documentation, and mitigation. Its core practical function is to ensure transparency and prompt response to incidents, thereby minimizing potential harm and clarifying responsibilities in the event of unforeseen problems.
Adverse Incidents. In the event of an adverse incident (significant clinical events, dispensing errors, adverse drug reactions), or near miss, it is imperative that the pharmacist will fill in an incident reporting form (available on Sonar) and forward a copy to NHS England within seven days.
Adverse Incidents. It is important that any issues, complaints or problems that arise from any participant of the system, including pharmacist, practice staff and patients; should be reported to NHS Barnet, as well as addressing the issues locally as part of the NHS complaints procedures. When informing the Trust, please complete an incident Reporting form. This should be forwarded to the Clinical Risk Manager as well as the Medicine Management Team. Participating surgeries will be expected to participate in monitoring and evaluation activities as required. The practice must allow the Commissioner’s internal and other nominated auditors access to all or any papers relating to the Minor Ailment Scheme for the purposes of audit. Applicable to: NHS Barnet Community Pharmacists who have been trained and accredited to provide the Barnet Minor Ailment Scheme Enclosed are the protocols for the 20 minor ailments included in the NHS Barnet Minor Ailment Scheme. These, along with the agreed formulary of allowable medicines under the scheme should be stored in the Minor Ailments Scheme Folder. These protocols have been approved by the Assistant Director, Medicines Management from NHS Barnet and Head of Medicines Management from NHS Enfield. The protocols are provided for you to use in your assessment and treatment of patients presenting with minor ailments Please consult each protocol regarding when to refer a patient. Please particularly note advice regarding pregnant or breastfeeding women and advice regarding children. Always refer to the manufacturers (or appropriate reference sources) most current advice available regarding drug use in pregnancy, breastfeeding and children. The protocols are provided as guidance only. It is therefore essential; that pharmacists base their advice and choice of medicine (if appropriate) on the needs of the individual patient, informed by appropriate up to date prescribing and other reference sources such as the Summary of Product Characteristics (SPC) or British National Formulary (BNF). Always refer to the manufacturers most current advice available regarding each drugs licensed indications, doses, contra-indications etc. Each individual pharmacist must act within his or her professional competence and responsibility. Please note – the National Collaborating Centre for Women’s and Children’s Health advise that as few conventional medicines have been established as safe to take during pregnancy, a general principle of the use of drugs in pregn...
Adverse Incidents. Provider shall report adverse incidents and information on unintended treatment outcomes to the Clinic’s Medical Director if such incidents and information pertain to a patient of the Clinic treated pursuant to this Agreement. Provider shall annually submit an adverse incident report that includes all information required by F.S. § 395.0197(6)(a), unless the adverse incident involves a result described by F.S. § 395.0197(8), in which case it shall be reported within 15 days after the occurrence of such incident. If an incident involves a professional licensed by the Department of Health, the Clinic shall submit such incident reports to the appropriate department or agency. All patient medical records and any identifying information contained in adverse incident reports and treatment outcomes which are obtained by System pursuant to this Section are confidential and exempt from public records requests.